Misoprostol plus oxytocin significantly cut primary postpartum hemorrhage incidence by 80% compared to oxytocin alone

Misoprostol combined with oxytocin significantly reduced primary postpartum hemorrhage incidence to 1.33% compared to 6.67% with oxytocin alone (p=0.018).